These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22878250)

  • 81. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
    Mueller SW; Kiser TH; Anderson TA; Neumann RT
    Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
    Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
    J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Abdominal abscess due to leuconostoc species in a liver transplant recipient.
    Montejo M; Grande C; Valdivieso A; Testillano M; Minguillan J; Aguirrebengoa K; Ortiz de Urbina J
    J Infect; 2000 Sep; 41(2):197-8. PubMed ID: 11023775
    [No Abstract]   [Full Text] [Related]  

  • 84. [Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
    Berberian G; Castro G; Fistolera S; Travaglianti M; Lopardo H; Mastroianni A; Rosanova MT
    Rev Argent Microbiol; 2009; 41(1):34-8. PubMed ID: 19391524
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
    Melzer M; Goldsmith D; Gransden W
    Clin Infect Dis; 2000 Jul; 31(1):208-9. PubMed ID: 10913433
    [No Abstract]   [Full Text] [Related]  

  • 86. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Enterococcus faecium cholangitis resistant to vancomycin and quinupristin-dalfopristin].
    Maseda E; Uña R; Ureta P; Royo C
    Med Clin (Barc); 2002 Sep; 119(7):276-7. PubMed ID: 12236991
    [No Abstract]   [Full Text] [Related]  

  • 88. Vancomycin-resistant Enterococcus in liver transplantation: what have we left behind?
    Fishman JA
    Transpl Infect Dis; 2003 Sep; 5(3):109-11. PubMed ID: 14617297
    [No Abstract]   [Full Text] [Related]  

  • 89. Enterococcal infection in kidney transplant recipients in a setting of low prevalence of vancomycin resistance.
    Fernández-Ruiz M; López-Medrano F; Andrés A; Morales JM; Aguado JM
    Transpl Infect Dis; 2014 Aug; 16(4):692-5. PubMed ID: 24964726
    [No Abstract]   [Full Text] [Related]  

  • 90. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.
    Raad II; Hanna HA; Hachem RY; Dvorak T; Arbuckle RB; Chaiban G; Rice LB
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3583-5. PubMed ID: 15328133
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
    Le J; Bookstaver PB; Rudisill CN; Hashem MG; Iqbal R; James CL; Sakoulas G
    Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluation of three disk tests for identification of enterococci, leuconostocs, and pediococci.
    Facklam R; Pigott N; Franklin R; Elliott J
    J Clin Microbiol; 1995 Apr; 33(4):885-7. PubMed ID: 7790454
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characterization of Leuconostoc lactis Bacteremia during a 2-year Study at a Tertiary Care Center in North India-An Observational Analysis.
    Tripathy S; Jamwal A; Varghese G; Sarawat D; Patel SS; Tejan N; Sahu C
    Am J Trop Med Hyg; 2024 Jul; 111(1):129-131. PubMed ID: 38834083
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Successful treatment of Enterococcus gallinarum infection in a neonate with vancomycin: a case report.
    Hao L; Wang H
    BMC Pediatr; 2024 Aug; 24(1):527. PubMed ID: 39148024
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria.
    Facklam R; Hollis D; Collins MD
    J Clin Microbiol; 1989 Apr; 27(4):724-30. PubMed ID: 2723037
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Odontogenic infection secondary to Leuconostoc species.
    Wenocur HS; Smith MA; Vellozzi EM; Shapiro J; Isenberg HD
    J Clin Microbiol; 1988 Sep; 26(9):1893-4. PubMed ID: 3183032
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Leuconostoc lactis and Staphylococcus nepalensis Bacteremia, Japan.
    Hosoya S; Kutsuna S; Shiojiri D; Tamura S; Isaka E; Wakimoto Y; Nomoto H; Ohmagari N
    Emerg Infect Dis; 2020 Sep; 26(9):2283-2285. PubMed ID: 32818417
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Meningitis caused by vancomycin-resistant Leuconostoc sp.
    Coovadia YM; Solwa Z; van den Ende J
    J Clin Microbiol; 1987 Sep; 25(9):1784-5. PubMed ID: 3654951
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Vancomycin-resistant streptococci or Leuconostoc sp.
    Buu-Hoï A; Branger C; Acar JF
    Antimicrob Agents Chemother; 1985 Sep; 28(3):458-60. PubMed ID: 4073868
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical laboratory challenges in the recognition of Leuconostoc spp.
    Isenberg HD; Vellozzi EM; Shapiro J; Rubin LG
    J Clin Microbiol; 1988 Mar; 26(3):479-83. PubMed ID: 3128577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.